A breast mesh lawsuit is a product liability claim against manufacturers of surgical mesh used in breast reconstruction, augmentation, lift, or revision surgery, alleging the mesh was promoted for breast procedures the FDA never cleared it for and caused injuries the manufacturer failed to warn about. As of mid-2026, cases are being filed individually. No multidistrict litigation has been created, no class action has been certified, and no settlements or verdicts have been reached.1ClassAction.org. Breast Mesh Internal Bra Lawsuit
What the Lawsuits Allege
The core allegation is a regulatory gap. The FDA has stated that no surgical mesh product has been cleared or approved for use in breast surgery of any kind.2BISA Nonprofit. What You Should Know About GalaFLEX Mesh Also Known as the Internal Bra Products like GalaFLEX were cleared through the FDA’s 510(k) pathway as general soft tissue reinforcement scaffolds, and their use in the breast is off-label.3Regulations.gov. FDA-2023-P-0916 In November 2023, the FDA issued a letter to healthcare providers regarding updated labels for BD’s Phasix and GalaFLEX product lines stating that safety and effectiveness for breast surgery has not been established. No breast mesh product has been recalled.4Drugwatch. Breast Mesh Lawsuit
Plaintiffs bring several overlapping theories:
- Failure to warn about breast-specific risks despite knowing surgeons were using the mesh in the breast.5McEldrew Purtell. Breast Mesh Lawsuits
- Defective design for the tissue environment and stresses of breast procedures.
- Inadequate clinical testing for the breast application before sale.
- Off-label promotion through marketing, surgeon training, and sales communications.6Doyle APC. Breast Mesh and Internal Bra Lawsuits
- Concealment of complication data.7Anapol Weiss. Defective Breast Mesh Complications What Patients Need to Know
BD denies the allegations, maintaining its products were properly cleared for soft tissue reinforcement and that complications often stem from surgical technique or risks inherent to breast surgery rather than device defects.8TorHoerman Law. Breast Mesh Lawsuit
Which Products and Manufacturers Are Involved
The mesh used inside the breast is often called an “internal bra”: a scaffold implanted to support tissue or an implant while the body deposits collagen, then absorbed over roughly six months to two years depending on the product.
The products most often named in current litigation are made by Becton, Dickinson and Company (BD):
- GalaFLEX, a poly-4-hydroxybutyrate (P4HB) scaffold, with variants including GalaFLEX Lite, GalaFLEX 3D, and GalaFLEX 3DR. BD acquired the line in July 2021 through its purchase of Tepha Inc.9Fierce Biotech. BD Fortifies Surgical Mesh Portfolio With Acquisition of Polymer Maker Tepha
- Phasix Mesh, Phasix ST Mesh, and configuration variants.1ClassAction.org. Breast Mesh Internal Bra Lawsuit
- DuraSorb, a polydioxanone mesh that resorbs in six to twelve months.10AMG Plastic Surgery. Internal Bra Surgery
Acellular dermal matrix (ADM) products derived from biological tissue, including AlloDerm, FlexHD, AlloMax, and SurgiMend, are also under investigation.11McEldrew Purtell. Breast Mesh Failures Chronic Pain Disfigurement After Internal Bra Procedures The FDA flagged AlloMax and FlexHD in a March 2021 safety communication as associated with higher rates of complications, explantation, and infection in breast reconstruction compared to other ADMs.12Oncology Nursing Society. FDA Issues Safety Communication ADM Products Used
Complications That Support a Claim
The injuries most commonly cited in filings and medical literature include infection (sometimes progressing to abscess or sepsis), seroma, capsular contracture, mesh migration or displacement, tissue erosion, chronic pain and nerve damage, and reconstruction failure.13TruLaw. Internal Bra Complications5McEldrew Purtell. Breast Mesh Lawsuits Roughly 13% of mesh recipients require complete implant removal, and a 2021 clinical study found that over one-third of patients experienced complications within six months of surgery. A 2024 review of 19 studies on synthetic mesh in breast reconstruction found reoperation in roughly 10% of cases.1ClassAction.org. Breast Mesh Internal Bra Lawsuit Adverse event reports filed with the FDA describe pain, foreign body reactions, and mesh that failed to dissolve as expected, requiring surgical removal.14FDA MAUDE. MAUDE Adverse Event Report 20925148
Who May Qualify
Attorneys are investigating claims from people who had breast reconstruction, augmentation, lift, or revision surgery in 2016 or later where mesh was used, and who then needed revision surgery or experienced serious complications.1ClassAction.org. Breast Mesh Internal Bra Lawsuit Qualifying complications include chronic pain, infection, seroma, capsular contracture, mesh migration, tissue erosion, implant failure, and the need for explant or corrective surgery.15YouHaveALawyer. Breast Mesh Lawsuit
A practical hurdle is identifying which specific mesh product was implanted. Defendants routinely contest product identification when medical records are incomplete or inconsistent. Operative reports, implant labels, hospital inventory records, pathology reports, and billing documentation are all used to confirm the product and manufacturer.8TorHoerman Law. Breast Mesh Lawsuit Requesting your full surgical file, not just the discharge summary, is usually the first step.
Deadlines to File
Statutes of limitations for product liability claims vary by state, typically running one to three years from when the injury was discovered or reasonably should have been discovered. Because mesh-related complications can emerge months or years after surgery, the exact deadline turns on state-specific discovery rules and the timeline of symptoms.15YouHaveALawyer. Breast Mesh Lawsuit Waiting to see how the litigation develops can cost you the case.
Where the Litigation Stands
Breast mesh cases are still early. There have been no settlements, no jury verdicts, and no findings of liability. Cases are being filed individually, and the federal Judicial Panel on Multidistrict Litigation’s pending docket as of April 2026 does not include a breast mesh MDL.16Jeffrey Glassman Injury Lawyers. Breast Mesh Lawsuit
Multiple suits have been filed in Rhode Island state court against Becton Dickinson and related subsidiaries, primarily involving GalaFLEX.8TorHoerman Law. Breast Mesh Lawsuit In January 2026, a separate suit alleged that mesh used in a cosmetic breast procedure caused excessive bleeding and hematoma requiring multiple corrective surgeries, framing the device as defective and unreasonably dangerous in a cosmetic setting.17TruLaw. Breast Mesh Lawsuits Consolidated proceedings are expected as filings grow.
Because no bellwether trials have occurred, individual case values cannot be projected. Factors that will affect any eventual compensation include the severity of injuries, whether revision or removal surgery was required, the duration of complications, and financial and emotional losses.4Drugwatch. Breast Mesh Lawsuit
How This Compares to Earlier Mesh Litigation
Two prior waves involved many of the same manufacturers. Transvaginal mesh became one of the largest mass torts in U.S. history: Boston Scientific paid $189 million in 2021, Johnson & Johnson settled for $117 million in 2019, and C.R. Bard (now part of BD) settled for $60 million in 2020.1ClassAction.org. Breast Mesh Internal Bra Lawsuit In October 2024, BD agreed to resolve approximately 38,000 hernia mesh lawsuits accumulated over 20 years; the amount was not disclosed, though BD said it fell within existing product litigation reserves.18BD News. BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
One thing sets breast mesh apart. Hernia mesh was at least cleared for the body area where it was used. No mesh product has ever received FDA clearance for breast surgery, and plaintiffs argue that gap makes the failure-to-warn and inadequate-testing theories stronger here than in earlier rounds.6Doyle APC. Breast Mesh and Internal Bra Lawsuits